An acute naproxen dose does not affect core temperature or Interleukin-6 during cycling in a hot environment
Dawn M. Emerson, Stephen CL. Chen, Toni M. Torres-McGehee, Craig E. Pfeifer, Charles C. Emerson, J. Mark Davis
An acute naproxen dose does not affect core temperature or Interleukin-6 during cycling in a hot environment
Non-steroidal anti-inflammatory drugs’ anti-pyretic and anti-inflammatory effects has led some individuals to theorize these medications may blunt core body temperature (Tc) increases during exercise. We utilized a double-blind, randomized, and counterbalanced cross-over design to examine the effects of a 24-h naproxen dose (3-220 mg naproxen pills) and placebo (0 mg naproxen) on Tc and plasma interleukin-6 (IL-6) concentrations during cycling in a hot or ambient environment. Participants (n = 11; 6 male, 5 female; age = 27.8 ± 6.5 years, weight = 79.1 ± 17.9 kg, height = 177 ± 9.5 cm) completed 4 conditions: 1) placebo and ambient (Control); 2) placebo and heat (Heat); 3) naproxen and ambient (Npx); and 4) naproxen and heat (NpxHeat). Dependent measures were taken before, during, and immediately after 90 min of cycling and then 3 h after cycling. Overall, Tc significantly increased pre- (37.1 ± 0.4 °C) to post-cycling (38.2 ± 0.3 °C, F1.7,67.3 = 150.5, p < 0.001) and decreased during rest (37.0 ± 0.3 °C, F2.0,81.5 = 201.6, p < 0.001). Rate of change or maximum Tc were not significantly different between conditions. IL-6 increased pre- (0.54 ± 0.06 pg/ml) to post-exercise (2.46 ± 0.28 pg/ml, p < 0.001) and remained significantly higher than pre-at 3 h post- (1.17 ± 0.14 pg/ml, 95% CI = −1.01 to −0.23, p = 0.001). No significant IL-6 differences occurred between conditions. A 24-h, over-the-counter naproxen dose did not significantly affect Tc or IL-6 among males and females cycling in hot or ambient environments.
Cytokine / Exertional heat illness / NSAIDs / Thermoregulation / Exercise
[[1]] |
|
[[2]] |
|
[[3]] |
|
[[4]] |
|
[[5]] |
|
[[6]] |
|
[[7]] |
|
[[8]] |
|
[[9]] |
|
[[10]] |
|
[[11]] |
|
[[12]] |
|
[[13]] |
|
[[14]] |
|
[[15]] |
|
[[16]] |
|
[[17]] |
|
[[18]] |
|
[[19]] |
|
[[20]] |
|
[[21]] |
|
[[22]] |
|
[[23]] |
|
[[24]] |
|
[[25]] |
|
[[26]] |
|
[[27]] |
|
[[28]] |
|
[[29]] |
|
[[30]] |
|
[[31]] |
|
[[32]] |
|
[[33]] |
|
[[34]] |
|
[[35]] |
|
[[36]] |
|
[[37]] |
|
[[38]] |
|
[[39]] |
|
[[40]] |
|
[[41]] |
|
[[42]] |
|
[[43]] |
|
[[44]] |
|
[[45]] |
|
[[46]] |
|
[[47]] |
|
[[48]] |
|
[[49]] |
|
[[50]] |
|
[[51]] |
|
[[52]] |
|
[[53]] |
|
We appreciate Dr. Brian Keisler, Dr. Reilly Enos, Dr. Angela Murphy, Kei Lam, and Hawthorne Pharmacy for their assistance and technical expertise toward this study. Thank you to Mr. Joseph Bivona and Mr. Justin Stone for their dedication and contributions toward data collection and analysis. We also thank Dr. Amy Hand and Mrs. Elena Burrus for assisting with data collection.
/
〈 | 〉 |